Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-24.65%
↓ 98% below average
Average (9y)
-12.45%
Historical baseline
Range
High:-0.81%
Low:-48.17%
CAGR
+40.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -24.65% | +48.8% |
| 2023 | -48.17% | -200.9% |
| 2022 | -16.01% | -663.5% |
| 2021 | -2.10% | +83.3% |
| 2020 | -12.55% | -2.3% |
| 2019 | -12.27% | -151.4% |
| 2018 | -4.88% | -503.7% |
| 2017 | -0.81% | +58.1% |
| 2016 | -1.93% | -64.8% |
| 2015 | -1.17% | - |